Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marsh

Showing results (871-880 of 897) with videos related to

Pageof 90
Sort By:
Journal of Medicinal Chemistry|December 22, 2006
Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesityLinus S Lin, Thomas J Lanza, James P Jewell, et al.
Human Molecular Genetics|April 18, 1998
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutationD J Marsh, V Coulon, K L Lunetta, et al.
Plos Genetics|November 27, 2023
Electrical synapse structure requires distinct isoforms of a postsynaptic scaffoldJennifer Carlisle Michel, Margaret M B Grivette, Amber T Harshfield, et al.
Human Mutation|January 1, 1996
Novel mutations and polymorphisms in the Fanconi anemia group C geneR A Gibson, N V Morgan, L H Goldstein, et al.
Journal of the American Heart Association|February 23, 2021
Early Pregnancy Atherogenic Profile in a First Pregnancy and Hypertension Risk 2 to 7 Years After DeliveryJanet M Catov, Rebecca B McNeil, Derek J Marsh, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Journal of the American Heart Association|October 1, 2019
Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years PostpartumDavid M Haas, Corette B Parker, Derek J Marsh, et al.
Plos Genetics|August 17, 2005
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomasPatricia L M Dahia, Ken N Ross, Matthew E Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodentsTung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 90

Showing results (871-880 of 897) with videos related to

Sort By:
Pageof 90
Journal of Medicinal Chemistry|December 22, 2006
Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesityLinus S Lin, Thomas J Lanza, James P Jewell, et al.
Human Molecular Genetics|April 18, 1998
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutationD J Marsh, V Coulon, K L Lunetta, et al.
Plos Genetics|November 27, 2023
Electrical synapse structure requires distinct isoforms of a postsynaptic scaffoldJennifer Carlisle Michel, Margaret M B Grivette, Amber T Harshfield, et al.
Human Mutation|January 1, 1996
Novel mutations and polymorphisms in the Fanconi anemia group C geneR A Gibson, N V Morgan, L H Goldstein, et al.
Journal of the American Heart Association|February 23, 2021
Early Pregnancy Atherogenic Profile in a First Pregnancy and Hypertension Risk 2 to 7 Years After DeliveryJanet M Catov, Rebecca B McNeil, Derek J Marsh, et al.
European Journal of Pharmacology|November 21, 2007
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodentsLauren P Shearman, D Sloan Stribling, Ramon E Camacho, et al.
Journal of the American Heart Association|October 1, 2019
Association of Adverse Pregnancy Outcomes With Hypertension 2 to 7 Years PostpartumDavid M Haas, Corette B Parker, Derek J Marsh, et al.
Plos Genetics|August 17, 2005
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomasPatricia L M Dahia, Ken N Ross, Matthew E Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodentsTung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Bioorganic & Medicinal Chemistry|April 13, 2012
The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerizationHarry R Chobanian, Yan Guo, Ping Liu, et al.
Pageof 90